ST Pharm Co.Ltd (237690) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ST Pharm Co.Ltd (237690) has a cash flow conversion efficiency ratio of -0.036x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-21.16 Billion ≈ $-14.34 Million USD) by net assets (₩593.00 Billion ≈ $401.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is ST Pharm Co.Ltd worth for the company's overall valuation and market capitalisation.
ST Pharm Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how ST Pharm Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ST Pharm Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ST Pharm Co.Ltd ranked by their cash flow conversion efficiency. Explore ST Pharm Co.Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zimplats Holdings Ltd
AU:ZIM
|
0.089x |
|
Ampoc Far-East Co Ltd
TW:2493
|
0.115x |
|
Elan Microelectronics Corp
TW:2458
|
0.095x |
|
Huizhou Speed Wireless Technology Co Ltd
SHE:300322
|
-0.085x |
|
Fox-Wizel Ltd
TA:FOX
|
0.018x |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
N/A |
|
OVH GROUPE UNSP.ADR/1/2
F:7U70
|
N/A |
|
Shenzhen Clou Electronics Co Ltd
SHE:002121
|
0.146x |
Annual Cash Flow Conversion Efficiency for ST Pharm Co.Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of ST Pharm Co.Ltd from 2015 to 2025. View current stock price of ST Pharm Co.Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩593.00 Billion ≈ $401.87 Million |
₩13.99 Billion ≈ $9.48 Million |
0.024x | -89.16% |
| 2024-12-31 | ₩502.99 Billion ≈ $340.87 Million |
₩109.45 Billion ≈ $74.17 Million |
0.218x | +6384.31% |
| 2023-12-31 | ₩386.91 Billion ≈ $262.20 Million |
₩1.30 Billion ≈ $879.90K |
0.003x | -83.89% |
| 2022-12-31 | ₩337.63 Billion ≈ $228.81 Million |
₩7.03 Billion ≈ $4.76 Million |
0.021x | -7.48% |
| 2021-12-31 | ₩322.97 Billion ≈ $218.87 Million |
₩7.27 Billion ≈ $4.93 Million |
0.023x | +131.75% |
| 2020-12-31 | ₩295.33 Billion ≈ $200.14 Million |
₩-20.93 Billion ≈ $-14.19 Million |
-0.071x | +30.09% |
| 2019-12-31 | ₩300.96 Billion ≈ $203.95 Million |
₩-30.52 Billion ≈ $-20.68 Million |
-0.101x | -412.25% |
| 2018-12-31 | ₩331.57 Billion ≈ $224.70 Million |
₩10.77 Billion ≈ $7.30 Million |
0.032x | -79.06% |
| 2017-12-31 | ₩351.08 Billion ≈ $237.92 Million |
₩54.44 Billion ≈ $36.89 Million |
0.155x | -4.35% |
| 2016-12-31 | ₩313.24 Billion ≈ $212.28 Million |
₩50.78 Billion ≈ $34.41 Million |
0.162x | -42.38% |
| 2015-12-31 | ₩127.33 Billion ≈ $86.29 Million |
₩35.82 Billion ≈ $24.28 Million |
0.281x | -- |
About ST Pharm Co.Ltd
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It… Read more